All the news Showing 9 of 9 articles from: Transmission and preventionGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Does drug injection equipment other than syringes transmit hepatitis C? Liz Highleyman / 19 September 2017 Sharing drug preparation paraphernalia may not significantly contribute to hepatitis C virus (HCV) transmission among people who inject drugs, according to a study recently published in The Journal of Infectious Diseases. In an experiment designed ... HCV treatment is effective and may work as prevention for people who inject drugs Liz Highleyman / 19 September 2016 Hepatitis C treatment for people who inject drugs is as safe and effective as it is for non-drug-users – with cure rates exceeding 90% – and treating enough people in this population could ... Only treating patients with cirrhosis with DAAs will have limited impact on HCV epidemic in England Michael Carter / 24 May 2016 Targeting new hepatitis C virus (HCV) direct-acting antivirals (DAAs) at patients with cirrhosis will substantially reduce short-term incidence of end-stage liver disease (ESLD) and liver cancer (HCC) in England, according to a model ... Emergency needle exchange in Indiana reduces HIV and HCV risk for people who inject drugs Liz Highleyman / 30 October 2015 An emergency syringe exchange program implemented after an outbreak of HIV earlier this year in the state of Indiana led to a decrease in risk behaviours including needle sharing during its first five ... Why is injecting equipment re-used? Drug users do their own research to find out Roger Pebody / 22 October 2015 Even in the context of the relatively good access to harm reduction services in Australia, the principle reasons for people who inject drugs to re-use syringes relate to the convenience of services, ... Treatment for prevention for hepatitis C in French drug users could cut HCV prevalence by two-thirds in 10 years Keith Alcorn / 12 April 2014 A combination of increased testing, improved linkage to care and treatment immediately after diagnosis with interferon-free regimens has the potential to substantially reduce the incidence and prevalence of hepatitis C virus ... Testing HCV positive has a sustained impact on drug injecting behaviour Michael Carter / 08 January 2014 Diagnosis with hepatitis C virus (HCV) is associated with a sustained reduction in injecting drug use, according to Canadian research published in the online edition of Clinical Infectious Diseases. Each additional three months ... Incidence of hepatitis C re-infection and clearance may be understimated Michael Carter / 26 April 2012 The incidence of hepatitis C re-infection among high-risk individuals who have spontaneously cleared the infection may be higher than previously assumed, a modelling study published in the May 1st edition of the ... Hepatitis C transmission via injecting drug use: look beyond needles and syringes Michael Carter / 04 November 2011 Important insights into the continued spread of hepatitis C among injecting drug users are provided by two studies published in the online edition of the Journal of Infectious Diseases. An international team of ... ← First1Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive